COMMUNITY HEALTHCARE TRUST I (CHCT) Stock Fundamental Analysis
NYSE:CHCT - New York Stock Exchange, Inc. - US20369C1062 - REIT - Currency: USD
We assign a fundamental rating of 4 out of 10 to CHCT. CHCT was compared to 129 industry peers in the Diversified REITs industry. While CHCT is still in line with the averages on profitability rating, there are concerns on its financial health. CHCT is valied quite expensively at the moment, while it does show a decent growth rate. Finally CHCT also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHCT was profitable.
CHCT had a positive operating cash flow in the past year.
Of the past 5 years CHCT 4 years were profitable.
CHCT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CHCT's Return On Assets of -0.52% is on the low side compared to the rest of the industry. CHCT is outperformed by 62.79% of its industry peers.
CHCT has a Return On Equity of -1.11%. This is in the lower half of the industry: CHCT underperforms 62.79% of its industry peers.
CHCT's Return On Invested Capital of 3.18% is fine compared to the rest of the industry. CHCT outperforms 61.24% of its industry peers.
CHCT had an Average Return On Invested Capital over the past 3 years of 2.59%. This is in line with the industry average of 3.15%.
The 3 year average ROIC (2.59%) for CHCT is below the current ROIC(3.18%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.52% | ||
| ROE | -1.11% | ||
| ROIC | 3.18% |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
1.3 Margins
CHCT's Operating Margin of 26.78% is in line compared to the rest of the industry. CHCT outperforms 58.91% of its industry peers.
CHCT's Operating Margin has declined in the last couple of years.
CHCT has a Gross Margin of 80.17%. This is in the better half of the industry: CHCT outperforms 79.84% of its industry peers.
In the last couple of years the Gross Margin of CHCT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.78% | ||
| PM (TTM) | N/A | ||
| GM | 80.17% |
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
2. Health
2.1 Basic Checks
CHCT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CHCT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CHCT has been increased compared to 5 years ago.
Compared to 1 year ago, CHCT has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.94, we must say that CHCT is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 0.94, CHCT is doing good in the industry, outperforming 72.09% of the companies in the same industry.
A Debt/Equity ratio of 1.08 is on the high side and indicates that CHCT has dependencies on debt financing.
The Debt to Equity ratio of CHCT (1.08) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.08 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.94 |
ROIC/WACC0.38
WACC8.34%
2.3 Liquidity
A Current Ratio of 0.56 indicates that CHCT may have some problems paying its short term obligations.
CHCT has a Current ratio of 0.56. This is in the lower half of the industry: CHCT underperforms 76.74% of its industry peers.
A Quick Ratio of 0.14 indicates that CHCT may have some problems paying its short term obligations.
CHCT's Quick ratio of 0.14 is on the low side compared to the rest of the industry. CHCT is outperformed by 92.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.14 |
3. Growth
3.1 Past
CHCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -78.69%.
CHCT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.22% yearly.
The Revenue has grown by 26.83% in the past year. This is a very strong growth!
CHCT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.73% yearly.
EPS 1Y (TTM)-78.69%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-72.73%
Revenue 1Y (TTM)26.83%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%2.54%
3.2 Future
Based on estimates for the next years, CHCT will show a very strong growth in Earnings Per Share. The EPS will grow by 41.23% on average per year.
CHCT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.86% yearly.
EPS Next Y-51.43%
EPS Next 2Y47.84%
EPS Next 3Y41.23%
EPS Next 5YN/A
Revenue Next Year4.9%
Revenue Next 2Y6.1%
Revenue Next 3Y8.3%
Revenue Next 5Y9.86%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 128.85, which means the current valuation is very expensive for CHCT.
Compared to the rest of the industry, the Price/Earnings ratio of CHCT indicates a slightly more expensive valuation: CHCT is more expensive than 64.34% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CHCT to the average of the S&P500 Index (26.32), we can say CHCT is valued expensively.
Based on the Price/Forward Earnings ratio of 36.49, the valuation of CHCT can be described as expensive.
66.67% of the companies in the same industry are more expensive than CHCT, based on the Price/Forward Earnings ratio.
CHCT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.19.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 128.85 | ||
| Fwd PE | 36.49 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHCT indicates a somewhat cheap valuation: CHCT is cheaper than 70.54% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 11.76 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CHCT's earnings are expected to grow with 41.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.84%
EPS Next 3Y41.23%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 11.11%, CHCT is a good candidate for dividend investing.
CHCT's Dividend Yield is rather good when compared to the industry average which is at 6.77. CHCT pays more dividend than 89.92% of the companies in the same industry.
CHCT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.11% |
5.2 History
The dividend of CHCT has a limited annual growth rate of 2.99%.
CHCT has been paying a dividend for at least 10 years, so it has a reliable track record.
As CHCT did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)2.99%
Div Incr Years9
Div Non Decr Years9
5.3 Sustainability
CHCT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CHCT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-1016.39%
EPS Next 2Y47.84%
EPS Next 3Y41.23%
NYSE:CHCT (6/18/2025, 10:30:37 AM)
16.75
+0.04 (+0.24%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners84.95%
Inst Owner Change1.67%
Ins Owners5.51%
Ins Owner Change3.59%
Market Cap474.69M
Analysts81.82
Price Target20.91 (24.84%)
Short Float %2.07%
Short Ratio2.5
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.11% |
Yearly Dividend1.85
Dividend Growth(5Y)2.99%
DP-1016.39%
Div Incr Years9
Div Non Decr Years9
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.98%
Min EPS beat(2)-57.98%
Max EPS beat(2)-43.98%
EPS beat(4)0
Avg EPS beat(4)-58.22%
Min EPS beat(4)-86.93%
Max EPS beat(4)-43.98%
EPS beat(8)1
Avg EPS beat(8)-39.86%
EPS beat(12)1
Avg EPS beat(12)-50%
EPS beat(16)1
Avg EPS beat(16)-41.01%
Revenue beat(2)0
Avg Revenue beat(2)-2.08%
Min Revenue beat(2)-3.64%
Max Revenue beat(2)-0.52%
Revenue beat(4)0
Avg Revenue beat(4)-4.24%
Min Revenue beat(4)-11.19%
Max Revenue beat(4)-0.52%
Revenue beat(8)0
Avg Revenue beat(8)-3.56%
Revenue beat(12)1
Avg Revenue beat(12)-2.76%
Revenue beat(16)3
Avg Revenue beat(16)-2.39%
PT rev (1m)-3.3%
PT rev (3m)-6.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-244.44%
EPS NY rev (1m)0%
EPS NY rev (3m)-72.97%
Revenue NQ rev (1m)0.54%
Revenue NQ rev (3m)-3.03%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-2.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 128.85 | ||
| Fwd PE | 36.49 | ||
| P/S | 3.25 | ||
| P/FCF | N/A | ||
| P/OCF | 7.83 | ||
| P/B | 1.03 | ||
| P/tB | 1.03 | ||
| EV/EBITDA | 11.76 |
EPS(TTM)0.13
EY0.78%
EPS(NY)0.46
Fwd EY2.74%
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)2.14
OCFY12.78%
SpS5.15
BVpS16.28
TBVpS16.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.52% | ||
| ROE | -1.11% | ||
| ROCE | 4.03% | ||
| ROIC | 3.18% | ||
| ROICexc | 3.19% | ||
| ROICexgc | 3.26% | ||
| OM | 26.78% | ||
| PM (TTM) | N/A | ||
| GM | 80.17% | ||
| FCFM | N/A |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
ROICexc(3y)2.61%
ROICexc(5y)2.94%
ROICexgc(3y)2.69%
ROICexgc(5y)3%
ROCE(3y)3.28%
ROCE(5y)3.7%
ROICexcg growth 3Y-9.66%
ROICexcg growth 5Y-0.75%
ROICexc growth 3Y-10.19%
ROICexc growth 5Y-1.2%
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
F-Score3
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.08 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.05 | ||
| Cap/Depr | 165.66% | ||
| Cap/Sales | 49.36% | ||
| Interest Coverage | 1.6 | ||
| Cash Conversion | 73.5% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.14 | ||
| Altman-Z | 0.94 |
F-Score3
WACC8.34%
ROIC/WACC0.38
Cap/Depr(3y)284.94%
Cap/Depr(5y)339.12%
Cap/Sales(3y)99.29%
Cap/Sales(5y)115.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-78.69%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-72.73%
EPS Next Y-51.43%
EPS Next 2Y47.84%
EPS Next 3Y41.23%
EPS Next 5YN/A
Revenue 1Y (TTM)26.83%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%2.54%
Revenue Next Year4.9%
Revenue Next 2Y6.1%
Revenue Next 3Y8.3%
Revenue Next 5Y9.86%
EBIT growth 1Y6.29%
EBIT growth 3Y-1.85%
EBIT growth 5Y10.76%
EBIT Next Year268.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y83.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.53%
OCF growth 3Y1.48%
OCF growth 5Y12.72%